poisar

Stocks · News reference

Profusa To Merge With Privately Held, Commercial-Stage Health Diagnostics And Toxicology Testing Company; Profusa To Issue 19.99% Stake to The Company And Will Issue Convertible Prefs; Combined Entity Operate As Public Diagnostics Firm

BenzingaJul 27, 2026, 10:05 AMBenzinga Newsdesk

Following the contemplated transaction, the combined company is expected to operate as a public diagnostics company with national CLIA-certified laboratories, recurring revenues from a diversified base of providers

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 27, 2026, 10:05 AM
Checked
Jul 27, 2026, 10:05 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading